What caused the volume spike in ZBH.SW stock today?

The intraday spike came with concentrated trading interest and a relVolume of **36.67x**. There was no single headline catalyst; traders are likely positioning ahead of the **2026-05-04** earnings date and technical tests of the 50‑day moving average.

Is ZBH.SW stock fairly valued versus peers?

Valuation is mixed. ZBH.SW shows **PE 24.11** and **PB 1.35**, below healthcare peer PE **35.08**. Strong free cash flow supports valuation, but leverage and inventory days suggest caution for long-term investors.

What price targets should traders watch for ZBH.SW stock?

Short-term levels: resistance **CHF78.58** (50‑day), support **CHF67.50** (year low). Analyst-style targets: conservative **CHF68.00**, base **CHF80.00**, bull **CHF95.00**. Use stops and watch volume to confirm moves.

How does Meyka AI rate ZBH.SW stock?

Meyka AI rates ZBH.SW with a score out of 100: **77.44** (Grade **B+**, Suggestion **BUY**). The grade weighs benchmarks, sector and financial growth, metrics, and consensus. This is informational, not investment advice.

CH Stocks

ZBH.SW Zimmer Biomet (SIX) at CHF75.00 24 Feb 2026: volume spike tests resistance

ByHuzaifa Zahoor February 24, 2026

Intraday action shows ZBH.SW stock trading at CHF75.00 on 24 Feb 2026 after a sharp volume spike that pushed the price +6.38% from yesterday’s close. The move places Zimmer Biomet Holdings, Inc. (ZBH.SW) on a near-term technical test against the 50‑day average of CHF78.58 and the stock’s year low of CHF67.50. Fundamentals are mixed: EPS CHF2.80 and PE 24.11, while free cash flow yield is 9.15%. Traders should watch whether the volume spike holds through the close, as it will shape the intraday trend and short-term trade setups.